Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation Research to Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana

NCT07389057 is registered in ClinicalTrials.gov with Noguchi Memorial Institute for Medical Research as lead sponsor.

NCT NCT07389057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07389057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation Research to Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana
Lead sponsor
Noguchi Memorial Institute for Medical Research
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2023
Completion date
November 30, 2026
Enrollment
9,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria asymptomatic parasitaemia, malaria falciparum, malaria infection, malaria transmission